擅长口腔颌面部肿瘤（涎腺肿瘤、口腔癌、颌骨囊肿）、颌面组织缺损修复、药物相关性（双膦酸盐）颌骨骨髓炎的诊断和治疗；并微创进行正畸减数牙、复杂牙、阻生齿拔除。

Dr. Guo was good at surgical treatment of maxillofacial tumors like salivary gland tumors or oral cancers, and medication-related osteonecrosis of the jaw and extraction of impacted teeth.

郭玉兴，男，河北唐山人，现为北京大学口腔医院副主任医师。2013年毕业于北京大学口腔医学院，获口腔颌面外科专业博士学位。2016年4月至2018年3月期间于美国南加州大学牙学院进行博士后培训，专注于间充质干细胞和破骨细胞间的相互作用机制。多年从事药物相关性颌骨骨髓炎（唑来膦酸、天晴依泰、择泰、博宁、安罗替尼、卡博替尼、地舒单抗）、口腔癌、颌面组织缺损修复及颅底-颞下区肿瘤的临床与基础研究。兼任中华口腔医学会口腔颌面-头颈肿瘤专委会青年委员和中国抗癌协会国际医疗交流专委会委员。2018年获邱蔚六口腔颌面外科发展基金“希望奖”，2019年获高等学校科学研究科学技术进步二等奖（第三完成人）。迄今以第一作者发表论文二十余篇（其中SCI10篇，总影响因子25），主持国自然青年基金1项，首都特色临床研究项目1项，校院项目2项。目前为《Cell Proliferation》和《中国生物化学与分子生物学报》审稿人。 Yuxing Guo, MD is a graduate of Peking University School of Stomotology, where he also attended his postgraduate studies, where graduated Hebei Medical University School of Stomotology with a Bachelor of Dental Surgery. Dr.Guo trained at the Peking University Hospital of Stomotology in Beijing at the Department of Oral and Maxillofacial Surgery. During his residency, he was able to carry out many operations of oral and maxillofacial oncology and rehabilitation, such as oral oncology resection, neck dissection, free flaps harvest, while simultaneously completing a clinical research of navigation-guided surgery. He eventually was licensed and began his career as a maxillofacial surgeon there. Afterwards, he completed a fellowship and postdoc training at Herman Ostrow School of Dentistry of USC, Center for Craniofacial Molecular Biology, with a publication related of the interplay between mesenchymal stem cells and osteoclast. Dr.Guo has been practicing in the Department of Oral and Maxillofacial Surgery at Peking University Hospital of Stomotology in Beijing since 2014, one of the top five oral cancer hospitals in China. His practice focuses on oral and maxillofacial oncology and rehabilitation, clinical treatment of medication-related osteonecrosis of the jaw (MRONJ), and basic research of cancer stem cells, drug resistance and bony invasion of oral squamous cell carcinoma. His research has been supported by the National Natural Science Foundation of China, Beijing Municipal Science and Technology Commission, Peking University Health Center, and Peking University Hospital of Stomatology. One of his hobbies is mentoring younger students and devotes time to running teaching and educational seminars for young students interested in the sciences and medicine. He currently has 10 English publications in maxillofacial-surgery field journals and over 10 Chinese publications. He is listed as an expert to treatment of medication-related osteonecrosis of the jaw (MRONJ) in China, currently according to therapy management dependent on MRONJ staging tailored to a patient’s individual drug-using history. Currently, Dr.Guo holds certification from the Oral and Maxillofacial-Head and Neck Cancer Committee of the Chinese Stomatological Association as a young border member. He was also awarded by Qiu Wei Liu Oral & Maxillofacial Surgery Development Foundation, and Science Technology Improvement Award of Science Research Achievement Award in Higher Education Institution of China for his contributions to navigation-guided surgery developments in the field of skull base tumors.